Jim Simons Renaissance Technologies
AUM
$75.2B
1-Year Return
41.49%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Quarter Return
+11.58%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$130B
AUM Growth
+$12B
(+10%)
Cap. Flow
+$3.31B
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
12.68%
Holding
3,913
New
518
Increased
1,840
Reduced
1,085
Closed
444
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76B |
| 2 |
Tesla
TSLA
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$623M |
| 4 |
AbbVie
ABBV
|
+$398M |
| 5 |
Qualcomm
QCOM
|
+$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$603M |
| 3 |
Micron Technology
MU
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$365M |
| 5 |
UnitedHealth
UNH
|
+$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Openlane
KAR
$3.07B
| $16.8M | 0.01% |
770,800
-647,400
| -46% | -$14.1M |
|
|
MSGN
1102
DELISTED
MSG Networks Inc.
MSGN
| $16.8M | 0.01% |
964,200
+237,300
| +33% | +$4.13M |
|
1103
Adverum Biotechnologies
ADVM
$63.4M
| $16.8M | 0.01% |
145,585
-123,715
| -46% | -$14.3M |
|
|
DFS
1104
DELISTED
Discover Financial Services
DFS
| $16.8M | 0.01% |
197,700
-355,900
| -64% | -$30.2M |
|
1105
IMAX
IMAX
$1.74B
| $16.7M | 0.01% |
818,800
+101,300
| +14% | +$2.07M |
|
1106
Regional Management Corp
RM
$418M
| $16.7M | 0.01% |
556,437
+15,200
| +3% | +$456K |
|
|
BRG
1107
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $16.7M | 0.01% |
1,383,963
+222,902
| +19% | +$2.69M |
|
|
EQC
1108
DELISTED
Equity Commonwealth
EQC
| $16.6M | 0.01% |
506,009
-788,151
| -61% | -$25.9M |
|
1109
Allot
ALLT
$426M
| $16.6M | 0.01% |
1,953,163
+151,537
| +8% | +$1.29M |
|
1110
Blue Bird Corp
BLBD
$1.84B
| $16.6M | 0.01% |
724,004
+228,404
| +46% | +$5.23M |
|
1111
Mondelez International
MDLZ
$80.2B
| $16.6M | 0.01% |
301,208
-3,902,547
| -93% | -$215M |
|
1112
First Commonwealth Financial
FCF
$1.84B
| $16.6M | 0.01% |
1,141,900
-210,700
| -16% | -$3.06M |
|
|
BBT
1113
Beacon Financial Corporation
BBT
$2.17B
| $16.6M | 0.01% |
503,879
+27,356
| +6% | +$899K |
|
1114
HealthStream
HSTM
$855M
| $16.5M | 0.01% |
607,900
+600
| +0.1% | +$16.3K |
|
|
LTM
1115
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $16.5M | 0.01% |
1,625,190
+312,200
| +24% | +$3.17M |
|
|
NBIS
1116
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.6B
| $16.5M | 0.01% |
+379,581
| New | +$16.5M |
|
1117
Euronet Worldwide
EEFT
$3.6B
| $16.5M | 0.01% |
104,645
+79,900
| +323% | +$12.6M |
|
1118
Mesa Laboratories
MLAB
$339M
| $16.4M | 0.01% |
65,900
-14,600
| -18% | -$3.64M |
|
1119
ANI Pharmaceuticals
ANIP
$2.12B
| $16.4M | 0.01% |
265,900
-67,300
| -20% | -$4.15M |
|
1120
Old Second Bancorp
OSBC
$961M
| $16.4M | 0.01% |
1,215,329
+35,904
| +3% | +$484K |
|
1121
Allstate
ALL
$52.8B
| $16.3M | 0.01% |
145,300
-842,800
| -85% | -$94.8M |
|
|
LTRPA
1122
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $16.3M | 0.01% |
2,222,321
+465,600
| +27% | +$3.42M |
|
|
EIGI
1123
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $16.3M | 0.01% |
3,474,100
+203,100
| +6% | +$955K |
|
1124
Flushing Financial
FFIC
$476M
| $16.2M | 0.01% |
751,360
+121,000
| +19% | +$2.61M |
|
1125
Ryman Hospitality Properties
RHP
$6.31B
| $16.2M | 0.01% |
186,737
-112,363
| -38% | -$9.74M |
|